Study Guide
Nursing
_ Comprehensive
CertificationOncology
Study
ExamGuide
&Nursing
Cancer
_ Comprehensive
Certification
Care Review.pdf
Study
ExamGuide
& Cancer
_ Comprehensive
Care Review.pdf
Exam & Cancer Care Review.pdf
Oncology Nursing Certification Study
Guide | Comprehensive Exam & Cancer
Care Review
Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_
Oncology Nursing CertificationOncology
Study Guide
Nursing
_ Comprehensive
CertificationOncology
Study
ExamGuide
&Nursing
Cancer
_ Comprehensive
Certification
Care Review.pdf
Study
ExamGuide
& Cancer
_ Comprehensive
Care Review.pdf
Exam & Cancer Care Review.pdf
,Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf
Terms in this set (125)
infiltration passage or escape of IV administered drugs into the tissue
extravasation leakage of drugs capable of causing tissue damage into the subcutaneous
or subdermal tissue or other unintended sites.
irritation a localized inflammatory reaction at the infusion or injection site
flare reaction a local allergic reaction along a vein caused by irritating drugs.
Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf
,Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf
infusion reactions reactions mediated by the immune system (hypersensitivity, anaphylaxis,
cytokine release syndrome)
DNA-binding vesicants vesicant binds to nucleic acids in the DNA of healthy cells in the tissue,
causing cell death. the dead cells then release complexes, which are taken
up by adjacent healthy cells. this process causes a continuing cycle of
tissue damage as the vesicant is retained in the tissue for a long period of
time.
NON-DNA binding vesicants the vesicant has an indirects effect on healthy cells. it does not bind to
cellular DNA. it is metabolized in the tissue and is more easily neutralized.
cabazitaxel ( jevtana) a taxane where infiltration has not caused skin or tissue impairment
Docetaxel (taxotere) extravasation may cause hyperpigmentation, erythema and tenderness.
Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf
, Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf
paclitaxel (taxol) injection site reactions, including reactions secondary to extravasation,
usually mild and consist of erythema, tenderness, skin hyperpigmentation
or swelling at injection site. seen more often with 24 hour infusions than
with 3 hour infusions. severe reactions such as phlebitis, cellulitis,
induration, skin exfoliation, necrosis and fibrosis have been reported. onset
has been delayed by a week to 10 days.
recall reactions recurrence of skin reactions at the site of previous extravasation following
paclitaxel injection at a different site.
docetaxel and paclitaxel classified as exfoliants or drugs that may cause inflammation and peeling
of skin without causing underlying tissue death.
Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf Oncology Certification Nursing.pdf